SCHOTT Pharma AG & Co. KGaA/€1SXP
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About SCHOTT Pharma AG & Co. KGaA
SCHOTT Pharma AG & Co. KGaA specializes in the design and manufacture of drug containment and delivery solutions for injectable medications, including prefillable glass and polymer syringes, cartridges, vials, and ampoules. Established as a standalone entity in August 2022 following its separation from SCHOTT AG, the company is headquartered in Mainz, Germany, and operates 16 manufacturing sites across Europe, North and South America, and Asia. With a portfolio of over 1,000 patents and a dedicated R&D center in Switzerland, SCHOTT Pharma focuses on developing innovative solutions to meet the evolving needs of the pharmaceutical industry. The company serves over 1,800 customers, including the top 30 pharmaceutical manufacturers for injectable drugs, and reported revenues of €821 million in the fiscal year 2022. SCHOTT Pharma is committed to sustainable development, aiming to achieve climate neutrality by 2030.
Ticker
€1SXP
Sector
Primary listing
XETRA
Employees
4,839
Headquarters
Website
1SXP Metrics
BasicAdvanced
€2.6bn
17.91
€0.95
0.89
€0.18
1.06%
Price and volume
Market cap
€2.6bn
Beta
0.89
52-week high
€29.95
52-week low
€12.54
Average daily volume
17k
Dividend rate
€0.18
Financial strength
Current ratio
1.587
Quick ratio
0.687
Long term debt to equity
8.231
Total debt to equity
31.97
Dividend payout ratio (TTM)
18.98%
Interest coverage (TTM)
10.02%
Profitability
EBITDA (TTM)
256.224
Gross margin (TTM)
32.94%
Net profit margin (TTM)
14.41%
Operating margin (TTM)
17.82%
Effective tax rate (TTM)
21.98%
Revenue per employee (TTM)
€200,000
Management effectiveness
Return on assets (TTM)
7.13%
Return on equity (TTM)
16.08%
Valuation
Price to earnings (TTM)
17.908
Price to revenue (TTM)
2.574
Price to book
2.75
Price to tangible book (TTM)
2.84
Price to free cash flow (TTM)
43.53
Free cash flow yield (TTM)
2.30%
Free cash flow per share (TTM)
0.391
Dividend yield (TTM)
1.06%
Forward dividend yield
1.06%
Growth
Revenue change (TTM)
1.80%
Earnings per share change (TTM)
-3.02%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs